MARÍA DEL CARMEN
GONZÁLEZ SAN SEGUNDO
Profesora asociada de Ciencias de la Salud
Hospital Universitario 12 de Octubre
Madrid, EspañaPublications in collaboration with researchers from Hospital Universitario 12 de Octubre (7)
2021
-
Impact of covid-19 on patients in radiotherapy oncology departaments in Spain
Radiotherapy and Oncology
-
Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial
Radiotherapy and Oncology, Vol. 160, pp. 115-119
2019
-
Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy
Radiotherapy and Oncology, Vol. 141, pp. 156-163
-
Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes
Clinical and Translational Oncology, Vol. 21, Núm. 8, pp. 1044-1051
2018
-
Consensus statement on definition, diagnosis, and management of high-risk prostate cancer patients on behalf of the Spanish Groups of Uro-Oncology Societies URONCOR, GUO, and SOGUG
Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 392-401
2016
-
Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial
International Journal of Radiation Oncology Biology Physics, Vol. 96, Núm. 2, pp. 341-348
2015
-
Nomogramme für die Prognose eines biochemischen Rezidivs beim Prostatakarzinom nach Strahlentherapie und Androgendeprivationstherapie
Strahlentherapie und Onkologie, Vol. 191, Núm. 10, pp. 792-800